Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial

European Journal of Cancer

Volumn 34, Issue 7, 1998, Pages 1036-1044

  Helsing, M ^a   Bergman, B ^b   Thaning, L ^a   Hero, U ^c  

^a ÖREBRO MEDICAL CENTRE HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UDDEVALLA HOSPITAL   (Sweden)

Author keywords

Best supportive care; Carboplatin; Chemotherapy; Etoposide; Non small cell lung cancer; Quality of life; Survival

Indexed keywords

CARBOPLATIN; ETOPOSIDE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; LUNG NON SMALL CELL CANCER; PATIENT MONITORING; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT PLANNING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COGNITION; DISEASE PROGRESSION; EMOTIONS; ETOPOSIDE; FEMALE; HEMATOLOGIC DISEASES; HUMANS; INTERPERSONAL RELATIONS; LUNG NEOPLASMS; MALE; MIDDLE AGED; QUALITY OF LIFE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032101806     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10122-8     Document Type: Article

References (28)

1. Souhami R. L., Stewart L. A., Arriagada R., Parmar M., Le Chevalier T., Pignon J. P. A data-based meta-analysis of randomised trials of chemotherapy versus best supportive care in advanced non-small cell lung cancer. Lung Cancer. 11:(Suppl. 2):1994;24-25.
2. Bergman B. Psychosocial issues in the treatment of patients with lung cancer. Lung Cancer. 8:1992;1-20.
3. Buccheri G. F., Ferrigno D., Curcio A., Vola F., Rosso A. Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Results of a randomized prospective study. Cancer. 63:1989;428-432.
4. Ganz P. A., Haskell C. M., Figlin R. A., la Soto N., Siau J. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index-Cancer. Cancer. 61:1988;849-856.
5. Ganz P. A., Figlin R. A., Haskell C. M., la Soto N., Siau J. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Cancer. 63:1989;1271-1278.
6. Kaasa S., Mastekaasa A. Psychosocial well-being of patients with inoperable non-small cell lung cancer. Acta Oncol. 27:1988;829-835.
7. Finkelstein D. M., Cassileth B. R., Bonomi P. D., Ruckdeshel J. C., Ezdinli E. Z., Wolter J. M. A pilot study of the Functional Living Index-Cancer (FLIC) scale for the assessment of quality of life for metastatic lung cancer patients. Am J Clin Oncol. 11:1988;630-633.
8. Fernandez C, Rosell R, Abad-Esteve A, et al. Quality of life during chemotherapy in non-small cell lung cancer patients. Acta Oncol 1989, 28, 29-33.
9. Schuster D., Heim M. E., Andres R. Quality of life of cancer patients under chemo- and radiotherapy. Prospective study of patients with gastrointestinal and bronchial cancer. Onkologie. 9:1986;172-180.
10. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85, 365-376.
11. Bergman B., Aaronson N. K., Ahmedzai S., Kaasa S., Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer. 30A:1994;635-642.
12. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977, 35, 1-39.
13. Dillman RO, Seagen SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990, 323, 940-945.
14. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1990, 83, 417-423.
15. Schaake-Koning C, Bogoert W van den, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy in inoperable non-small cell lung cancer. N Engl J Med 1992, 326, 524-530.
16. Maasilta P. K., Rautonen J. K., Mattson M. T., Mattson K. V. Quality of life assessment during chemotherapy for non-small cell lung cancer. Eur J Cancer. 26A:1990;706-708.
17. Bergman B., Sullivan M., Sörenson S. Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures. Acta Oncol. 30:1991;947-957.
18. Thongprasert S, Sanguanmitra P, Juthapan W. Final report on quality of life and clinical outcomes in advanced non-small cell lung cancer. Proc ASCO 1996, 1244.
19. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995, 311, 899-909.
20. Rapp E, Pater JL, Willan A, et al. Chemotherapy can prolong survival in patients with advanced non-small cell lung cancer - Report of a Canadian multicenter randomized trial. J Clin Oncol 1988, 6, 633-641.
21. Woods RL, Williams CS, Page J, et al. A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 1990, 61, 608-611.
22. Quoix E, Dietermann A, Charbonneau J, et al. La chimiothérapie comportant du cisplatine est elle utile dans le cancer bronchique non microcellulaire au stade IV: resultats d'une étude randomisée. Bull Cancer 1991, 78, 341-346.
23. Kaasa S, Lund E, Thorud E, et al. Symptomatic treatment versus combination chemotherapy for patients with extensive non-small cell lung cancer. Cancer 1991, 67, 2443-2447.
24. Cellerino R, Tumarello D, Guidi F, et al. A randomized trial of alternating combination chemotherapy versus best supportive care in advanced non-small cell lung cancer. J Clin Oncol 1991, 9, 1453-1461.
25. Buccheri G, Ferrigno D, Rosso A, et al. Further evidence in favor of chemotherapy for inoperable non-small cell lung cancer. Lung Cancer 1990, 6, 87-98.
26. Bunn P. A. Jr. The expanding role of cisplatin in the treatment of non-small cell lung cancer. Semin Oncol. 16:(Suppl. 6):1989;10-21.
27. Bonomi PD, Finkelstein DM, Ruckdeschel JC, et al. Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: a study of the Eastern Cooperative Oncology Group. J Clin Oncol 1989, 7, 1602-1613.
28. Klastersky J, Sculier J-P, Lacroix H, et al. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European Organization for Research and Treatment of Cancer protocol 07861. J Clin Oncol 1990, 8, 1556-1562.